Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London
· Delayed Price · Currency is GBP · Price in GBX 1,127.50
+77.50 (7.38%)
Mar 9, 2026, 4:46 PM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 72.45 million as of March 9, 2026. Its market cap has increased by 471.80% in one year.
Market Cap
72.45M
Enterprise Value
74.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,127.50
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 72.45M, an increase of 578.26%. That is a compound annual growth rate of 25.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 61.94M |
| hVIVO | 56.47M |
| Bioventix | 80.99M |
| 4basebio | 83.58M |
| Ondine Biomedical | 53.25M |
| ImmuPharma | 35.19M |
| Scancell Holdings | 133.35M |
| SkinBioTherapeutics | 32.40M |